Exploring the Potential Targets and Mechanisms of Huang Lian Jie Du Decoction in the Treatment of Coronavirus Disease 2019 Based on Network Pharmacology

References

• Zheng J. SARS-CoV-2: an emerging coronavirus that causes a global threat. Int J Biol Sci. 2020;16:1678. doi:10.7150/ijbs.45053
   PubMed Web of Science ®Google Scholar
• Lu R, Zhao X, Li J, et al. Genomic characterisation and epidemiology of 2019 novel coronavirus: implications for virus origins and receptor binding. Lancet. 2020;395:565–574. doi:10.1016/S0140-6736(20)30251-8
   PubMed Web of Science ®Google Scholar
• Isakbaeva ET, Khetsuriani N, Beard RS, et al. SARS-associated coronavirus transmission, United States. Emerg Infect Dis. 2004;10:225–231. doi:10.3201/eid1002.030734
   PubMed Web of Science ®Google Scholar
• Zhai P, Ding Y, Wu X, Long J, Zhong Y, Li Y. The epidemiology, diagnosis and treatment of COVID-19. Int J Antimicrob Agents. 2020;55:105955. doi:10.1016/j.ijantimicag.2020.105955
   PubMed Web of Science ®Google Scholar
• Nkengasong J. China’s response to a novel coronavirus stands in stark contrast to the 2002 SARS outbreak response. Nat Med. 2020;26:310–311.
   PubMed Web of Science ®Google Scholar
• Su S, Wong G, Shi W, et al. Epidemiology, genetic recombination, and pathogenesis of coronaviruses. Trends Microbiol. 2016;24:490–502. doi:10.1016/j.tim.2016.03.003
   PubMed Web of Science ®Google Scholar
• Chan JF-W, Kok K-H, Zhu Z, et al. Genomic characterization of the 2019 novel human-pathogenic coronavirus isolated from a patient with atypical pneumonia after visiting Wuhan. Emerg Microb Infect. 2020;9:221–236. doi:10.1080/22221751.2020.1719902
   PubMed Web of Science ®Google Scholar
• Zhou P, Yang X-L, Wang X-G, et al. A pneumonia outbreak associated with a new coronavirus of probable bat origin. Nature. 2020;579:270–273. doi:10.1038/s41586-020-2012-7
   PubMed Web of Science ®Google Scholar
• Richardson P, Griffin I, Tucker C, et al. Baricitinib as potential treatment for 2019-nCoV acute respiratory disease. Lancet. 2020;395:e30. doi:10.1016/S0140-6736(20)30304-4
   PubMed Web of Science ®Google Scholar
• Gralinski LE, Menachery VD. Return of the coronavirus: 2019-nCoV. Viruses. 2020;12:135. doi:10.3390/v12020135
   PubMed Web of Science ®Google Scholar
• Zumla A, Hui DS, Azhar EI, Memish ZA, Maeurer M. Reducing mortality from 2019-nCoV: host-directed therapies should be an option. Lancet. 2020;395:e35–e36. doi:10.1016/S0140-6736(20)30305-6
   PubMed Web of Science ®Google Scholar
• Xu X-W, Wu -X-X, Jiang X-G, et al. Clinical findings in a group of patients infected with the 2019 novel coronavirus (SARS-Cov-2) outside of Wuhan, China: retrospective case series. BMJ. 2020;368:m606.
   PubMed Web of Science ®Google Scholar
• Poston JT, Patel BK, Davis AM. Management of critically ill adults with COVID-19. JAMA. 2020. doi:10.1001/jama.2020.4914
   PubMed Web of Science ®Google Scholar
• Bennardo F, Buffone C, Giudice A. New therapeutic opportunities for COVID-19 patients with Tocilizumab: possible correlation of interleukin-6 receptor inhibitors with osteonecrosis of the jaws. Oral Oncol. 2020:104659. doi:10.1016/j.oraloncology.2020.104659
   PubMed Web of Science ®Google Scholar
• Oshima N, Narukawa Y, Hada N, Kiuchi F. Quantitative analysis of anti-inflammatory activity of orengedokuto: importance of combination of flavonoids in inhibition of PGE 2 production in mouse macrophage-like cell line J774. 1. J Nat Med. 2013;67:281–288. doi:10.1007/s11418-012-0679-2
   PubMed Web of Science ®Google Scholar
• Tanaka K, Nara K, Nishimura T, et al. Fever of unknown origin successfully treated by oren-gedoku-to (huanglian-jie-du-tang). Int J Gen Med. 2013;6:829. doi:10.2147/IJGM.S52488
   PubMedGoogle Scholar
• Chen M, Liao Z, Lu B, et al. Huang-Lian-Jie-Du-decoction ameliorates hyperglycemia and insulin resistant in association with gut microbiota modulation. Front Microbiol. 2018;9:2380. doi:10.3389/fmicb.2018.02380
   PubMed Web of Science ®Google Scholar
• Lu J, Wang J-S, Kong L-Y. Anti-inflammatory effects of Huang-Lian-Jie-Du decoction, its two fractions and four typical compounds. J Ethnopharmacol. 2011;134:911–918. doi:10.1016/j.jep.2011.01.049
   PubMed Web of Science ®Google Scholar
• Zhang Q, Fu X, Wang J, Yang M, Kong L. Treatment effects of ischemic stroke by berberine, baicalin, and jasminoidin from Huang-Lian-Jie-Du-Decoction (HLJDD) explored by an integrated metabolomics approach. Oxid Med Cell Longev. 2017;2017:1–20. doi:10.1155/2017/9848594
   Web of Science ®Google Scholar
• Hopkins AL. Network pharmacology: the next paradigm in drug discovery. Nat Chem Biol. 2008;4:682. doi:10.1038/nchembio.118
   PubMed Web of Science ®Google Scholar
• Ru J, Li P, Wang J, et al. TCMSP: a database of systems pharmacology for drug discovery from herbal medicines. J Cheminform. 2014;6:13. doi:10.1186/1758-2946-6-13
   PubMed Web of Science ®Google Scholar
• Wang P, Zhou W, Meng J, Huo H, Sui F. Inter-module coupling analysis of Huang-Lian-Jie-Du-Decoction on stroke. Front Pharmacol. 2019;10:1288. doi:10.3389/fphar.2019.01288
   PubMed Web of Science ®Google Scholar
• Chen ML, Shah V, Patnaik R, et al. Bioavailability and bioequivalence: an FDA regulatory overview. Pharm Res. 2001;18:1645–1650. doi:10.1023/a:1013319408893
   PubMed Web of Science ®Google Scholar
• Zuegg J, Cooper MA. Drug-likeness and increased hydrophobicity of commercially available compound libraries for drug screening. Curr Top Med Chem. 2012;12:1500–1513. doi:10.2174/156802612802652466
   PubMed Web of Science ®Google Scholar
• Zhang W, Chen Y, Jiang H, et al. Integrated strategy for accurately screening biomarkers based on metabolomics coupled with network pharmacology. Talanta. 2020;211:120710. doi:10.1016/j.talanta.2020.120710
   PubMed Web of Science ®Google Scholar
• UniProt Consortium. UniProt: a worldwide hub of protein knowledge. Nucleic Acids Res. 2019;47:D506–D515. doi:10.1093/nar/gky1049
   PubMed Web of Science ®Google Scholar
• Stelzer G, Rosen N, Plaschkes I, et al. The GeneCards suite: from gene data mining to disease genome sequence analyses. Curr Protoc Bioinformatics. 2016;54:1–30. doi:10.1002/cpbi.5
   PubMedGoogle Scholar
• Hamosh A, Scott AF, Amberger JS, Bocchini CA, McKusick VA. Online Mendelian Inheritance in Man (OMIM), a knowledgebase of human genes and genetic disorders. Nucleic Acids Res. 2005;33:D514–D517. doi:10.1093/nar/gki033
   PubMed Web of Science ®Google Scholar
• Szklarczyk D, Franceschini A, Wyder S, et al. STRING v10: protein–protein interaction networks, integrated over the tree of life. Nucleic Acids Res. 2015;43:D447–D452. doi:10.1093/nar/gku1003
   PubMed Web of Science ®Google Scholar
• Otasek D, Morris JH, Bouças J, Pico AR, Demchak B. Cytoscape automation: empowering workflow-based network analysis. Genome Biol. 2019;20:1–15. doi:10.1186/s13059-019-1758-4
   PubMed Web of Science ®Google Scholar
• Dennis G, Sherman BT, Hosack DA, et al. DAVID: database for annotation, visualization, and integrated discovery. Genome Biol. 2003;4:R60. doi:10.1186/gb-2003-4-9-r60
   Web of Science ®Google Scholar
• Lu H. Drug treatment options for the 2019-new coronavirus (2019-nCoV). Biosci Trends. 2020;14:69–71. doi:10.5582/bst.2020.01020
   PubMed Web of Science ®Google Scholar
• Wang M, Cao R, Zhang L, et al. Remdesivir and chloroquine effectively inhibit the recently emerged novel coronavirus (2019-nCoV) in vitro. Cell Res. 2020;30:269–271. doi:10.1038/s41422-020-0282-0
   PubMed Web of Science ®Google Scholar
• Zhao Z, Li Y, Zhou L, et al. Prevention and treatment of COVID-19 using Traditional Chinese Medicine: a review. Phytomedicine. 2021;85:153308. doi:10.1016/j.phymed.2020.153308
   PubMed Web of Science ®Google Scholar
• Cao Y, Gao C, Sun J, Wang J, Zhou Q, Liu G. Study on pharmacological effects of Huanglianjiedu Tang extract. J China Pharm Univ. 1996;27:605–608.
   Google Scholar
• Tang F, Tang Q, Tian Y, Fan Q, Huang Y, Tan X. Network pharmacology-based prediction of the active ingredients and potential targets of Mahuang Fuzi Xixin decoction for application to allergic rhinitis. J Ethnopharmacol. 2015;176:402–412. doi:10.1016/j.jep.2015.10.040
   PubMed Web of Science ®Google Scholar
• Yang Y, Wang H-J, Yang J, et al. Chemical profiling and quantification of Chinese medicinal formula Huang-Lian-Jie-Du decoction, a systematic quality control strategy using ultra high performance liquid chromatography combined with hybrid quadrupole-orbitrap and triple quadrupole mass spectrometers. J Chromatogr A. 2013;1321:88–99. doi:10.1016/j.chroma.2013.10.072
   PubMed Web of Science ®Google Scholar
• Zhi H, Jin X, Zhu H, et al. Exploring the effective materials of flavonoids-enriched extract from Scutellaria baicalensis roots based on the metabolic activation in influenza A virus induced acute lung injury. J Pharm Biomed Anal. 2020;177:112876. doi:10.1016/j.jpba.2019.112876
   PubMed Web of Science ®Google Scholar
• Song J, Zhang L, Xu Y, et al. The comprehensive study on the therapeutic effects of baicalein for the treatment of COVID-19 in vivo and in vitro. Biochem Pharmacol. 2021;183:114302. doi:10.1016/j.bcp.2020.114302
   PubMed Web of Science ®Google Scholar
• Liu H, Ye F, Sun Q, et al. Scutellaria baicalensis extract and baicalein inhibit replication of SARS-CoV-2 and its 3C-like protease in vitro. J Enzyme Inhib Med Chem. 2021;36:497–503. doi:10.1080/14756366.2021.1873977
   PubMed Web of Science ®Google Scholar
• Luganini A, Mercorelli B, Messa L, Palù G, Gribaudo G, Loregian A. The isoquinoline alkaloid berberine inhibits human cytomegalovirus replication by interfering with the viral Immediate Early-2 (IE2) protein transactivating activity. Antiviral Res. 2019;164:52–60. doi:10.1016/j.antiviral.2019.02.006
   PubMed Web of Science ®Google Scholar
• Lee B-H, Chathuranga K, Uddin MB, et al. Coptidis Rhizoma extract inhibits replication of respiratory syncytial virus in vitro and in vivo by inducing antiviral state. J Microbiol. 2017;55:488–498. doi:10.1007/s12275-017-7088-x
   PubMed Web of Science ®Google Scholar
• Jo S, Kim H, Kim S, Shin DH, Kim MS. Characteristics of flavonoids as potent MERS‐CoV 3C‐like protease inhibitors. Chem Biol Drug Des. 2019;94:2023–2030. doi:10.1111/cbdd.13604
   PubMed Web of Science ®Google Scholar
• Bi C, Dong X, Zhong X, Cai H, Wang D, Wang L. Acacetin protects mice from Staphylococcus aureus bloodstream infection by inhibiting the activity of sortase A. Molecules. 2016;21:1285. doi:10.3390/molecules21101285
   PubMed Web of Science ®Google Scholar
• Huang W-C, Liou C-J. Dietary acacetin reduces airway hyperresponsiveness and eosinophil infiltration by modulating eotaxin-1 and th2 cytokines in a mouse model of asthma. Evid Based Complement Alternat Med. 2012;2012:1–11. doi:10.1155/2012/910520
   Web of Science ®Google Scholar
• Qi Y, Zhang Q, Zhu H. Huang-Lian Jie-Du decoction: a review on phytochemical, pharmacological and pharmacokinetic investigations. Chin Med. 2019;14:57. doi:10.1186/s13020-019-0277-2
   PubMed Web of Science ®Google Scholar
• Runfeng L, Yunlong H, Jicheng H, et al. Lianhuaqingwen exerts anti-viral and anti-inflammatory activity against novel coronavirus (SARS-CoV-2). Pharmacol Res. 2020;156:104761. doi:10.1016/j.phrs.2020.104761
   PubMed Web of Science ®Google Scholar
• Panteva M, Korkaya H, Jameel S. Hepatitis viruses and the MAPK pathway: is this a survival strategy? Virus Res. 2003;92:131–140.
   PubMed Web of Science ®Google Scholar
• Huang C, Wang Y, Li X, et al. Clinical features of patients infected with 2019 novel coronavirus in Wuhan, China. Lancet. 2020;395:497–506. doi:10.1016/S0140-6736(20)30183-5
   PubMed Web of Science ®Google Scholar
• Choudhary S, Sharma K, Silakari O. The interplay between inflammatory pathways and COVID-19: a critical review on pathogenesis and therapeutic options. Microb Pathog. 2021;150:104673. doi:10.1016/j.micpath.2020.104673
   PubMed Web of Science ®Google Scholar
• Du J, Abdel-Razek O, Shi Q, et al. Surfactant protein D attenuates acute lung and kidney injuries in pneumonia-induced sepsis through modulating apoptosis, inflammation and NF-κB signaling. Sci Rep. 2018;8:1–14. doi:10.1038/s41598-018-33828-7
   PubMed Web of Science ®Google Scholar
• Kim Y, Allen E, Baird LA, et al. NF-κB RelA is required for hepatoprotection during pneumonia and sepsis. Infect Immun. 2019;87:e00132–00119. doi:10.1128/IAI.00132-19
   PubMed Web of Science ®Google Scholar
• Guo X, Zhu Z, Zhang W, et al. Nuclear translocation of HIF-1α induced by influenza A (H1N1) infection is critical to the production of proinflammatory cytokines: HIF-1α nuclear translocation induced by H1N1. Emerg Microb Infect. 2017;6:1–8. doi:10.1038/emi.2017.21
   PubMed Web of Science ®Google Scholar
• Rothe J, Gehr G, Loetscher H, Lesslauer W. Tumor necrosis factor receptors-structure and function. Immunol Res. 1992;11:81–90. doi:10.1007/BF02918612
   PubMed Web of Science ®Google Scholar
• Li L-L, Dai B, Sun Y-H, Zhang T-T. Monocytes undergo functional reprogramming to generate immunosuppression through HIF-1α signaling pathway in the late phase of sepsis. Mediators Inflamm. 2020;2020:1–9. doi:10.1155/2020/4235909
   Web of Science ®Google Scholar